nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—KCNJ11—epilepsy syndrome	0.299	0.828	CbGaD
Repaglinide—ALB—epilepsy syndrome	0.0623	0.172	CbGaD
Repaglinide—ALB—Oxcarbazepine—epilepsy syndrome	0.0325	0.079	CbGbCtD
Repaglinide—ALB—Fosphenytoin—epilepsy syndrome	0.0284	0.069	CbGbCtD
Repaglinide—ALB—Clonazepam—epilepsy syndrome	0.0257	0.0624	CbGbCtD
Repaglinide—CYP2C8—Trimethadione—epilepsy syndrome	0.0234	0.0568	CbGbCtD
Repaglinide—CYP2C8—Fosphenytoin—epilepsy syndrome	0.022	0.0534	CbGbCtD
Repaglinide—ALB—Rufinamide—epilepsy syndrome	0.021	0.0509	CbGbCtD
Repaglinide—ALB—Phenytoin—epilepsy syndrome	0.0183	0.0445	CbGbCtD
Repaglinide—ALB—Propofol—epilepsy syndrome	0.0171	0.0415	CbGbCtD
Repaglinide—CYP2C8—Carbamazepine—epilepsy syndrome	0.0158	0.0383	CbGbCtD
Repaglinide—ALB—Diazepam—epilepsy syndrome	0.0155	0.0376	CbGbCtD
Repaglinide—CYP2C8—Primidone—epilepsy syndrome	0.0147	0.0358	CbGbCtD
Repaglinide—CYP2C8—Phenytoin—epilepsy syndrome	0.0142	0.0344	CbGbCtD
Repaglinide—CYP2C8—Propofol—epilepsy syndrome	0.0132	0.0321	CbGbCtD
Repaglinide—CYP2C8—Phenobarbital—epilepsy syndrome	0.0126	0.0306	CbGbCtD
Repaglinide—CYP2C8—Diazepam—epilepsy syndrome	0.012	0.0291	CbGbCtD
Repaglinide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0102	0.0248	CbGbCtD
Repaglinide—CYP3A4—Trimethadione—epilepsy syndrome	0.00948	0.023	CbGbCtD
Repaglinide—CYP3A4—Felbamate—epilepsy syndrome	0.00948	0.023	CbGbCtD
Repaglinide—CYP2C8—Valproic Acid—epilepsy syndrome	0.00944	0.0229	CbGbCtD
Repaglinide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00892	0.0216	CbGbCtD
Repaglinide—CYP3A4—Clonazepam—epilepsy syndrome	0.00806	0.0196	CbGbCtD
Repaglinide—CYP3A4—Clobazam—epilepsy syndrome	0.00773	0.0188	CbGbCtD
Repaglinide—CYP3A4—Rufinamide—epilepsy syndrome	0.00657	0.016	CbGbCtD
Repaglinide—CYP3A4—Carbamazepine—epilepsy syndrome	0.00641	0.0155	CbGbCtD
Repaglinide—CYP3A4—Primidone—epilepsy syndrome	0.00598	0.0145	CbGbCtD
Repaglinide—CYP3A4—Phenytoin—epilepsy syndrome	0.00575	0.0139	CbGbCtD
Repaglinide—CYP3A4—Propofol—epilepsy syndrome	0.00536	0.013	CbGbCtD
Repaglinide—CYP3A4—Acetazolamide—epilepsy syndrome	0.00512	0.0124	CbGbCtD
Repaglinide—CYP3A4—Phenobarbital—epilepsy syndrome	0.00512	0.0124	CbGbCtD
Repaglinide—CYP3A4—Midazolam—epilepsy syndrome	0.00505	0.0123	CbGbCtD
Repaglinide—CYP3A4—Diazepam—epilepsy syndrome	0.00485	0.0118	CbGbCtD
Repaglinide—CYP3A4—Zonisamide—epilepsy syndrome	0.00474	0.0115	CbGbCtD
Repaglinide—CYP3A4—Valproic Acid—epilepsy syndrome	0.00383	0.00929	CbGbCtD
Repaglinide—CYP3A4—Topiramate—epilepsy syndrome	0.00345	0.00838	CbGbCtD
Repaglinide—PPARG—forelimb—epilepsy syndrome	0.00171	0.199	CbGeAlD
Repaglinide—ABCC8—brainstem—epilepsy syndrome	0.000527	0.0613	CbGeAlD
Repaglinide—ABCC8—forebrain—epilepsy syndrome	0.000509	0.0592	CbGeAlD
Repaglinide—ABCC8—telencephalon—epilepsy syndrome	0.000468	0.0544	CbGeAlD
Repaglinide—PPARG—forebrain—epilepsy syndrome	0.000389	0.0452	CbGeAlD
Repaglinide—ABCC8—medulla oblongata—epilepsy syndrome	0.000368	0.0428	CbGeAlD
Repaglinide—ABCC8—midbrain—epilepsy syndrome	0.000336	0.0391	CbGeAlD
Repaglinide—ABCC8—spinal cord—epilepsy syndrome	0.000328	0.0381	CbGeAlD
Repaglinide—KCNJ11—head—epilepsy syndrome	0.000316	0.0368	CbGeAlD
Repaglinide—KCNJ11—nervous system—epilepsy syndrome	0.0003	0.0349	CbGeAlD
Repaglinide—ABCC8—head—epilepsy syndrome	0.000291	0.0339	CbGeAlD
Repaglinide—KCNJ11—central nervous system—epilepsy syndrome	0.000289	0.0336	CbGeAlD
Repaglinide—KCNJ11—cerebellum—epilepsy syndrome	0.000282	0.0328	CbGeAlD
Repaglinide—ABCC8—nervous system—epilepsy syndrome	0.000276	0.0321	CbGeAlD
Repaglinide—ABCC8—central nervous system—epilepsy syndrome	0.000266	0.0309	CbGeAlD
Repaglinide—ABCC8—cerebellum—epilepsy syndrome	0.00026	0.0302	CbGeAlD
Repaglinide—KCNJ11—brain—epilepsy syndrome	0.000229	0.0267	CbGeAlD
Repaglinide—PPARG—head—epilepsy syndrome	0.000223	0.0259	CbGeAlD
Repaglinide—ABCC8—brain—epilepsy syndrome	0.000211	0.0246	CbGeAlD
Repaglinide—PPARG—nervous system—epilepsy syndrome	0.000211	0.0245	CbGeAlD
Repaglinide—PPARG—central nervous system—epilepsy syndrome	0.000203	0.0236	CbGeAlD
Repaglinide—PPARG—brain—epilepsy syndrome	0.000161	0.0187	CbGeAlD
Repaglinide—ALB—brain—epilepsy syndrome	0.000151	0.0176	CbGeAlD
Repaglinide—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000113	0.00085	CcSEcCtD
Repaglinide—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000113	0.00085	CcSEcCtD
Repaglinide—Arrhythmia—Pregabalin—epilepsy syndrome	0.000112	0.000843	CcSEcCtD
Repaglinide—Headache—Acetazolamide—epilepsy syndrome	0.000112	0.000841	CcSEcCtD
Repaglinide—Urticaria—Zonisamide—epilepsy syndrome	0.000112	0.000839	CcSEcCtD
Repaglinide—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000112	0.000838	CcSEcCtD
Repaglinide—Abdominal pain—Zonisamide—epilepsy syndrome	0.000111	0.000835	CcSEcCtD
Repaglinide—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000111	0.000835	CcSEcCtD
Repaglinide—Visual impairment—Gabapentin—epilepsy syndrome	0.000111	0.000834	CcSEcCtD
Repaglinide—Alopecia—Pregabalin—epilepsy syndrome	0.000111	0.000834	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000111	0.000834	CcSEcCtD
Repaglinide—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000111	0.000833	CcSEcCtD
Repaglinide—Constipation—Carbamazepine—epilepsy syndrome	0.00011	0.000826	CcSEcCtD
Repaglinide—Diarrhoea—Levetiracetam—epilepsy syndrome	0.00011	0.000824	CcSEcCtD
Repaglinide—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.00011	0.000823	CcSEcCtD
Repaglinide—Pruritus—Fosphenytoin—epilepsy syndrome	0.00011	0.000822	CcSEcCtD
Repaglinide—Hypersensitivity—Diazepam—epilepsy syndrome	0.00011	0.000822	CcSEcCtD
Repaglinide—Dyspepsia—Lamotrigine—epilepsy syndrome	0.00011	0.000821	CcSEcCtD
Repaglinide—Malnutrition—Pregabalin—epilepsy syndrome	0.00011	0.000821	CcSEcCtD
Repaglinide—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000109	0.00082	CcSEcCtD
Repaglinide—Erythema multiforme—Gabapentin—epilepsy syndrome	0.000109	0.000818	CcSEcCtD
Repaglinide—Leukopenia—Valproic Acid—epilepsy syndrome	0.000109	0.000813	CcSEcCtD
Repaglinide—Urticaria—Clonazepam—epilepsy syndrome	0.000108	0.000809	CcSEcCtD
Repaglinide—Eye disorder—Gabapentin—epilepsy syndrome	0.000108	0.000809	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000107	0.000806	CcSEcCtD
Repaglinide—Abdominal pain—Clonazepam—epilepsy syndrome	0.000107	0.000805	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	0.000107	0.000804	CcSEcCtD
Repaglinide—Urticaria—Phenytoin—epilepsy syndrome	0.000107	0.000804	CcSEcCtD
Repaglinide—Cardiac disorder—Gabapentin—epilepsy syndrome	0.000107	0.000803	CcSEcCtD
Repaglinide—Palpitations—Valproic Acid—epilepsy syndrome	0.000107	0.000803	CcSEcCtD
Repaglinide—Pruritus—Vigabatrin—epilepsy syndrome	0.000107	0.000802	CcSEcCtD
Repaglinide—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000107	0.000799	CcSEcCtD
Repaglinide—Constipation—Lamotrigine—epilepsy syndrome	0.000106	0.000798	CcSEcCtD
Repaglinide—Nausea—Acetazolamide—epilepsy syndrome	0.000106	0.000797	CcSEcCtD
Repaglinide—CYP2C8—brain—epilepsy syndrome	0.000106	0.0124	CbGeAlD
Repaglinide—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000106	0.000795	CcSEcCtD
Repaglinide—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000106	0.000795	CcSEcCtD
Repaglinide—Back pain—Pregabalin—epilepsy syndrome	0.000106	0.000795	CcSEcCtD
Repaglinide—Vomiting—Propofol—epilepsy syndrome	0.000106	0.000793	CcSEcCtD
Repaglinide—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000105	0.00079	CcSEcCtD
Repaglinide—Pruritus—Diazepam—epilepsy syndrome	0.000105	0.000789	CcSEcCtD
Repaglinide—Urinary tract infection—Topiramate—epilepsy syndrome	0.000105	0.000788	CcSEcCtD
Repaglinide—Rash—Propofol—epilepsy syndrome	0.000105	0.000786	CcSEcCtD
Repaglinide—Dermatitis—Propofol—epilepsy syndrome	0.000105	0.000785	CcSEcCtD
Repaglinide—Hypertension—Valproic Acid—epilepsy syndrome	0.000105	0.000784	CcSEcCtD
Repaglinide—Immune system disorder—Gabapentin—epilepsy syndrome	0.000104	0.000782	CcSEcCtD
Repaglinide—Headache—Propofol—epilepsy syndrome	0.000104	0.000781	CcSEcCtD
Repaglinide—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000104	0.000779	CcSEcCtD
Repaglinide—Vomiting—Midazolam—epilepsy syndrome	0.000103	0.000775	CcSEcCtD
Repaglinide—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000103	0.000775	CcSEcCtD
Repaglinide—Arthralgia—Valproic Acid—epilepsy syndrome	0.000103	0.000774	CcSEcCtD
Repaglinide—Chest pain—Valproic Acid—epilepsy syndrome	0.000103	0.000774	CcSEcCtD
Repaglinide—Rash—Midazolam—epilepsy syndrome	0.000103	0.000769	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000103	0.000768	CcSEcCtD
Repaglinide—Dermatitis—Midazolam—epilepsy syndrome	0.000103	0.000768	CcSEcCtD
Repaglinide—Urticaria—Carbamazepine—epilepsy syndrome	0.000102	0.000767	CcSEcCtD
Repaglinide—Vomiting—Levetiracetam—epilepsy syndrome	0.000102	0.000766	CcSEcCtD
Repaglinide—Alopecia—Gabapentin—epilepsy syndrome	0.000102	0.000765	CcSEcCtD
Repaglinide—Headache—Midazolam—epilepsy syndrome	0.000102	0.000764	CcSEcCtD
Repaglinide—Pruritus—Felbamate—epilepsy syndrome	0.000102	0.000764	CcSEcCtD
Repaglinide—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000102	0.000763	CcSEcCtD
Repaglinide—Diarrhoea—Diazepam—epilepsy syndrome	0.000102	0.000763	CcSEcCtD
Repaglinide—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000102	0.000763	CcSEcCtD
Repaglinide—Sinusitis—Topiramate—epilepsy syndrome	0.000102	0.000761	CcSEcCtD
Repaglinide—Rash—Levetiracetam—epilepsy syndrome	0.000101	0.000759	CcSEcCtD
Repaglinide—Dermatitis—Levetiracetam—epilepsy syndrome	0.000101	0.000759	CcSEcCtD
Repaglinide—Headache—Levetiracetam—epilepsy syndrome	0.000101	0.000754	CcSEcCtD
Repaglinide—Erythema—Gabapentin—epilepsy syndrome	0.000101	0.000753	CcSEcCtD
Repaglinide—Malnutrition—Gabapentin—epilepsy syndrome	0.000101	0.000753	CcSEcCtD
Repaglinide—Hypersensitivity—Clonazepam—epilepsy syndrome	0.0001	0.00075	CcSEcCtD
Repaglinide—Pruritus—Zonisamide—epilepsy syndrome	9.98e-05	0.000748	CcSEcCtD
Repaglinide—Hypersensitivity—Phenytoin—epilepsy syndrome	9.94e-05	0.000745	CcSEcCtD
Repaglinide—Oedema—Valproic Acid—epilepsy syndrome	9.89e-05	0.000742	CcSEcCtD
Repaglinide—Anaphylactic shock—Valproic Acid—epilepsy syndrome	9.89e-05	0.000742	CcSEcCtD
Repaglinide—Urticaria—Lamotrigine—epilepsy syndrome	9.89e-05	0.000741	CcSEcCtD
Repaglinide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	9.89e-05	0.000741	CcSEcCtD
Repaglinide—Nausea—Propofol—epilepsy syndrome	9.88e-05	0.00074	CcSEcCtD
Repaglinide—Vomiting—Fosphenytoin—epilepsy syndrome	9.86e-05	0.000739	CcSEcCtD
Repaglinide—Diarrhoea—Felbamate—epilepsy syndrome	9.86e-05	0.000739	CcSEcCtD
Repaglinide—Abdominal pain—Lamotrigine—epilepsy syndrome	9.84e-05	0.000738	CcSEcCtD
Repaglinide—Leukopenia—Pregabalin—epilepsy syndrome	9.81e-05	0.000735	CcSEcCtD
Repaglinide—Rash—Fosphenytoin—epilepsy syndrome	9.78e-05	0.000733	CcSEcCtD
Repaglinide—Dermatitis—Fosphenytoin—epilepsy syndrome	9.77e-05	0.000732	CcSEcCtD
Repaglinide—Rhinitis—Topiramate—epilepsy syndrome	9.74e-05	0.00073	CcSEcCtD
Repaglinide—Back pain—Gabapentin—epilepsy syndrome	9.72e-05	0.000729	CcSEcCtD
Repaglinide—Headache—Fosphenytoin—epilepsy syndrome	9.72e-05	0.000728	CcSEcCtD
Repaglinide—Hepatitis—Topiramate—epilepsy syndrome	9.71e-05	0.000728	CcSEcCtD
Repaglinide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	9.69e-05	0.000726	CcSEcCtD
Repaglinide—Palpitations—Pregabalin—epilepsy syndrome	9.69e-05	0.000726	CcSEcCtD
Repaglinide—Nausea—Midazolam—epilepsy syndrome	9.67e-05	0.000724	CcSEcCtD
Repaglinide—Diarrhoea—Zonisamide—epilepsy syndrome	9.65e-05	0.000723	CcSEcCtD
Repaglinide—Pruritus—Clonazepam—epilepsy syndrome	9.61e-05	0.000721	CcSEcCtD
Repaglinide—Vomiting—Vigabatrin—epilepsy syndrome	9.61e-05	0.00072	CcSEcCtD
Repaglinide—Skin disorder—Valproic Acid—epilepsy syndrome	9.61e-05	0.00072	CcSEcCtD
Repaglinide—Oedema peripheral—Topiramate—epilepsy syndrome	9.57e-05	0.000717	CcSEcCtD
Repaglinide—Pruritus—Phenytoin—epilepsy syndrome	9.55e-05	0.000716	CcSEcCtD
Repaglinide—Nausea—Levetiracetam—epilepsy syndrome	9.54e-05	0.000715	CcSEcCtD
Repaglinide—Rash—Vigabatrin—epilepsy syndrome	9.53e-05	0.000714	CcSEcCtD
Repaglinide—Dermatitis—Vigabatrin—epilepsy syndrome	9.52e-05	0.000714	CcSEcCtD
Repaglinide—Pruritus—Oxcarbazepine—epilepsy syndrome	9.5e-05	0.000712	CcSEcCtD
Repaglinide—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.49e-05	0.000711	CcSEcCtD
Repaglinide—Headache—Vigabatrin—epilepsy syndrome	9.47e-05	0.00071	CcSEcCtD
Repaglinide—Hypertension—Pregabalin—epilepsy syndrome	9.46e-05	0.000709	CcSEcCtD
Repaglinide—Vomiting—Diazepam—epilepsy syndrome	9.46e-05	0.000709	CcSEcCtD
Repaglinide—CYP3A4—nervous system—epilepsy syndrome	9.42e-05	0.011	CbGeAlD
Repaglinide—Rash—Diazepam—epilepsy syndrome	9.38e-05	0.000703	CcSEcCtD
Repaglinide—Dermatitis—Diazepam—epilepsy syndrome	9.37e-05	0.000703	CcSEcCtD
Repaglinide—Visual impairment—Topiramate—epilepsy syndrome	9.36e-05	0.000702	CcSEcCtD
Repaglinide—Arthralgia—Pregabalin—epilepsy syndrome	9.33e-05	0.000699	CcSEcCtD
Repaglinide—Chest pain—Pregabalin—epilepsy syndrome	9.33e-05	0.000699	CcSEcCtD
Repaglinide—Headache—Diazepam—epilepsy syndrome	9.32e-05	0.000699	CcSEcCtD
Repaglinide—Diarrhoea—Clonazepam—epilepsy syndrome	9.3e-05	0.000697	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	9.27e-05	0.000695	CcSEcCtD
Repaglinide—Diarrhoea—Phenytoin—epilepsy syndrome	9.23e-05	0.000692	CcSEcCtD
Repaglinide—Nausea—Fosphenytoin—epilepsy syndrome	9.21e-05	0.00069	CcSEcCtD
Repaglinide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.19e-05	0.000688	CcSEcCtD
Repaglinide—Erythema multiforme—Topiramate—epilepsy syndrome	9.18e-05	0.000688	CcSEcCtD
Repaglinide—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.17e-05	0.000688	CcSEcCtD
Repaglinide—Vomiting—Felbamate—epilepsy syndrome	9.16e-05	0.000686	CcSEcCtD
Repaglinide—Pruritus—Carbamazepine—epilepsy syndrome	9.12e-05	0.000683	CcSEcCtD
Repaglinide—Rash—Felbamate—epilepsy syndrome	9.08e-05	0.000681	CcSEcCtD
Repaglinide—Eye disorder—Topiramate—epilepsy syndrome	9.08e-05	0.00068	CcSEcCtD
Repaglinide—Dermatitis—Felbamate—epilepsy syndrome	9.07e-05	0.00068	CcSEcCtD
Repaglinide—CYP3A4—central nervous system—epilepsy syndrome	9.07e-05	0.0105	CbGeAlD
Repaglinide—Headache—Felbamate—epilepsy syndrome	9.02e-05	0.000676	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	9.01e-05	0.000676	CcSEcCtD
Repaglinide—Cardiac disorder—Topiramate—epilepsy syndrome	9.01e-05	0.000676	CcSEcCtD
Repaglinide—Leukopenia—Gabapentin—epilepsy syndrome	9e-05	0.000674	CcSEcCtD
Repaglinide—Nausea—Vigabatrin—epilepsy syndrome	8.98e-05	0.000673	CcSEcCtD
Repaglinide—Vomiting—Zonisamide—epilepsy syndrome	8.96e-05	0.000672	CcSEcCtD
Repaglinide—Anaphylactic shock—Pregabalin—epilepsy syndrome	8.95e-05	0.00067	CcSEcCtD
Repaglinide—Oedema—Pregabalin—epilepsy syndrome	8.95e-05	0.00067	CcSEcCtD
Repaglinide—Rash—Zonisamide—epilepsy syndrome	8.89e-05	0.000666	CcSEcCtD
Repaglinide—Paraesthesia—Valproic Acid—epilepsy syndrome	8.88e-05	0.000666	CcSEcCtD
Repaglinide—Palpitations—Gabapentin—epilepsy syndrome	8.88e-05	0.000666	CcSEcCtD
Repaglinide—Dermatitis—Zonisamide—epilepsy syndrome	8.88e-05	0.000666	CcSEcCtD
Repaglinide—Nausea—Diazepam—epilepsy syndrome	8.84e-05	0.000663	CcSEcCtD
Repaglinide—Headache—Zonisamide—epilepsy syndrome	8.83e-05	0.000662	CcSEcCtD
Repaglinide—Diarrhoea—Carbamazepine—epilepsy syndrome	8.82e-05	0.000661	CcSEcCtD
Repaglinide—Pruritus—Lamotrigine—epilepsy syndrome	8.81e-05	0.00066	CcSEcCtD
Repaglinide—Immune system disorder—Topiramate—epilepsy syndrome	8.77e-05	0.000658	CcSEcCtD
Repaglinide—Thrombocytopenia—Pregabalin—epilepsy syndrome	8.76e-05	0.000656	CcSEcCtD
Repaglinide—Dyspepsia—Valproic Acid—epilepsy syndrome	8.71e-05	0.000653	CcSEcCtD
Repaglinide—Skin disorder—Pregabalin—epilepsy syndrome	8.69e-05	0.000651	CcSEcCtD
Repaglinide—Hypertension—Gabapentin—epilepsy syndrome	8.68e-05	0.00065	CcSEcCtD
Repaglinide—Vomiting—Clonazepam—epilepsy syndrome	8.64e-05	0.000648	CcSEcCtD
Repaglinide—Alopecia—Topiramate—epilepsy syndrome	8.58e-05	0.000643	CcSEcCtD
Repaglinide—Vomiting—Phenytoin—epilepsy syndrome	8.58e-05	0.000643	CcSEcCtD
Repaglinide—Rash—Clonazepam—epilepsy syndrome	8.57e-05	0.000642	CcSEcCtD
Repaglinide—Dermatitis—Clonazepam—epilepsy syndrome	8.56e-05	0.000642	CcSEcCtD
Repaglinide—Chest pain—Gabapentin—epilepsy syndrome	8.56e-05	0.000641	CcSEcCtD
Repaglinide—Arthralgia—Gabapentin—epilepsy syndrome	8.56e-05	0.000641	CcSEcCtD
Repaglinide—Nausea—Felbamate—epilepsy syndrome	8.56e-05	0.000641	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.54e-05	0.00064	CcSEcCtD
Repaglinide—Vomiting—Oxcarbazepine—epilepsy syndrome	8.54e-05	0.00064	CcSEcCtD
Repaglinide—Diarrhoea—Lamotrigine—epilepsy syndrome	8.52e-05	0.000639	CcSEcCtD
Repaglinide—Headache—Clonazepam—epilepsy syndrome	8.51e-05	0.000638	CcSEcCtD
Repaglinide—Rash—Phenytoin—epilepsy syndrome	8.51e-05	0.000638	CcSEcCtD
Repaglinide—Dermatitis—Phenytoin—epilepsy syndrome	8.5e-05	0.000637	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	8.5e-05	0.000637	CcSEcCtD
Repaglinide—Rash—Oxcarbazepine—epilepsy syndrome	8.47e-05	0.000634	CcSEcCtD
Repaglinide—Constipation—Valproic Acid—epilepsy syndrome	8.46e-05	0.000634	CcSEcCtD
Repaglinide—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.46e-05	0.000634	CcSEcCtD
Repaglinide—Headache—Phenytoin—epilepsy syndrome	8.46e-05	0.000634	CcSEcCtD
Repaglinide—Malnutrition—Topiramate—epilepsy syndrome	8.46e-05	0.000634	CcSEcCtD
Repaglinide—Erythema—Topiramate—epilepsy syndrome	8.46e-05	0.000634	CcSEcCtD
Repaglinide—Headache—Oxcarbazepine—epilepsy syndrome	8.41e-05	0.00063	CcSEcCtD
Repaglinide—Nausea—Zonisamide—epilepsy syndrome	8.37e-05	0.000628	CcSEcCtD
Repaglinide—Anaphylactic shock—Gabapentin—epilepsy syndrome	8.2e-05	0.000615	CcSEcCtD
Repaglinide—Oedema—Gabapentin—epilepsy syndrome	8.2e-05	0.000615	CcSEcCtD
Repaglinide—Vomiting—Carbamazepine—epilepsy syndrome	8.19e-05	0.000614	CcSEcCtD
Repaglinide—Back pain—Topiramate—epilepsy syndrome	8.18e-05	0.000613	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.15e-05	0.000611	CcSEcCtD
Repaglinide—Rash—Carbamazepine—epilepsy syndrome	8.12e-05	0.000609	CcSEcCtD
Repaglinide—Dermatitis—Carbamazepine—epilepsy syndrome	8.12e-05	0.000608	CcSEcCtD
Repaglinide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.09e-05	0.000606	CcSEcCtD
Repaglinide—Nausea—Clonazepam—epilepsy syndrome	8.07e-05	0.000605	CcSEcCtD
Repaglinide—Headache—Carbamazepine—epilepsy syndrome	8.07e-05	0.000605	CcSEcCtD
Repaglinide—Paraesthesia—Pregabalin—epilepsy syndrome	8.03e-05	0.000602	CcSEcCtD
Repaglinide—Thrombocytopenia—Gabapentin—epilepsy syndrome	8.03e-05	0.000602	CcSEcCtD
Repaglinide—Nausea—Phenytoin—epilepsy syndrome	8.02e-05	0.000601	CcSEcCtD
Repaglinide—Nausea—Oxcarbazepine—epilepsy syndrome	7.97e-05	0.000598	CcSEcCtD
Repaglinide—Skin disorder—Gabapentin—epilepsy syndrome	7.97e-05	0.000597	CcSEcCtD
Repaglinide—Vomiting—Lamotrigine—epilepsy syndrome	7.92e-05	0.000593	CcSEcCtD
Repaglinide—Urticaria—Valproic Acid—epilepsy syndrome	7.86e-05	0.000589	CcSEcCtD
Repaglinide—Rash—Lamotrigine—epilepsy syndrome	7.85e-05	0.000588	CcSEcCtD
Repaglinide—Dermatitis—Lamotrigine—epilepsy syndrome	7.84e-05	0.000588	CcSEcCtD
Repaglinide—Abdominal pain—Valproic Acid—epilepsy syndrome	7.82e-05	0.000586	CcSEcCtD
Repaglinide—Headache—Lamotrigine—epilepsy syndrome	7.8e-05	0.000585	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.72e-05	0.000579	CcSEcCtD
Repaglinide—Nausea—Carbamazepine—epilepsy syndrome	7.65e-05	0.000574	CcSEcCtD
Repaglinide—Constipation—Pregabalin—epilepsy syndrome	7.65e-05	0.000573	CcSEcCtD
Repaglinide—Leukopenia—Topiramate—epilepsy syndrome	7.57e-05	0.000567	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.47e-05	0.00056	CcSEcCtD
Repaglinide—Palpitations—Topiramate—epilepsy syndrome	7.47e-05	0.00056	CcSEcCtD
Repaglinide—Nausea—Lamotrigine—epilepsy syndrome	7.4e-05	0.000554	CcSEcCtD
Repaglinide—Paraesthesia—Gabapentin—epilepsy syndrome	7.37e-05	0.000552	CcSEcCtD
Repaglinide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.31e-05	0.000548	CcSEcCtD
Repaglinide—Hypertension—Topiramate—epilepsy syndrome	7.3e-05	0.000547	CcSEcCtD
Repaglinide—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.29e-05	0.000546	CcSEcCtD
Repaglinide—Dyspepsia—Gabapentin—epilepsy syndrome	7.22e-05	0.000541	CcSEcCtD
Repaglinide—Arthralgia—Topiramate—epilepsy syndrome	7.2e-05	0.00054	CcSEcCtD
Repaglinide—Chest pain—Topiramate—epilepsy syndrome	7.2e-05	0.00054	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7.15e-05	0.000536	CcSEcCtD
Repaglinide—Urticaria—Pregabalin—epilepsy syndrome	7.11e-05	0.000533	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.08e-05	0.000531	CcSEcCtD
Repaglinide—Abdominal pain—Pregabalin—epilepsy syndrome	7.07e-05	0.00053	CcSEcCtD
Repaglinide—Constipation—Gabapentin—epilepsy syndrome	7.01e-05	0.000526	CcSEcCtD
Repaglinide—Pruritus—Valproic Acid—epilepsy syndrome	7e-05	0.000525	CcSEcCtD
Repaglinide—Oedema—Topiramate—epilepsy syndrome	6.9e-05	0.000517	CcSEcCtD
Repaglinide—Diarrhoea—Valproic Acid—epilepsy syndrome	6.77e-05	0.000507	CcSEcCtD
Repaglinide—Thrombocytopenia—Topiramate—epilepsy syndrome	6.76e-05	0.000506	CcSEcCtD
Repaglinide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.71e-05	0.000503	CcSEcCtD
Repaglinide—Skin disorder—Topiramate—epilepsy syndrome	6.7e-05	0.000502	CcSEcCtD
Repaglinide—Hypersensitivity—Pregabalin—epilepsy syndrome	6.59e-05	0.000494	CcSEcCtD
Repaglinide—Urticaria—Gabapentin—epilepsy syndrome	6.52e-05	0.000488	CcSEcCtD
Repaglinide—Abdominal pain—Gabapentin—epilepsy syndrome	6.48e-05	0.000486	CcSEcCtD
Repaglinide—Pruritus—Pregabalin—epilepsy syndrome	6.33e-05	0.000474	CcSEcCtD
Repaglinide—Vomiting—Valproic Acid—epilepsy syndrome	6.29e-05	0.000471	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.29e-05	0.000471	CcSEcCtD
Repaglinide—Rash—Valproic Acid—epilepsy syndrome	6.24e-05	0.000468	CcSEcCtD
Repaglinide—Dermatitis—Valproic Acid—epilepsy syndrome	6.23e-05	0.000467	CcSEcCtD
Repaglinide—Headache—Valproic Acid—epilepsy syndrome	6.2e-05	0.000465	CcSEcCtD
Repaglinide—Paraesthesia—Topiramate—epilepsy syndrome	6.2e-05	0.000464	CcSEcCtD
Repaglinide—Diarrhoea—Pregabalin—epilepsy syndrome	6.12e-05	0.000459	CcSEcCtD
Repaglinide—Dyspepsia—Topiramate—epilepsy syndrome	6.07e-05	0.000455	CcSEcCtD
Repaglinide—Hypersensitivity—Gabapentin—epilepsy syndrome	6.04e-05	0.000453	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.96e-05	0.000447	CcSEcCtD
Repaglinide—Constipation—Topiramate—epilepsy syndrome	5.9e-05	0.000442	CcSEcCtD
Repaglinide—Nausea—Valproic Acid—epilepsy syndrome	5.88e-05	0.00044	CcSEcCtD
Repaglinide—Pruritus—Gabapentin—epilepsy syndrome	5.8e-05	0.000435	CcSEcCtD
Repaglinide—Vomiting—Pregabalin—epilepsy syndrome	5.69e-05	0.000426	CcSEcCtD
Repaglinide—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.64e-05	0.000423	CcSEcCtD
Repaglinide—Rash—Pregabalin—epilepsy syndrome	5.64e-05	0.000423	CcSEcCtD
Repaglinide—Dermatitis—Pregabalin—epilepsy syndrome	5.63e-05	0.000422	CcSEcCtD
Repaglinide—Diarrhoea—Gabapentin—epilepsy syndrome	5.61e-05	0.000421	CcSEcCtD
Repaglinide—Headache—Pregabalin—epilepsy syndrome	5.6e-05	0.00042	CcSEcCtD
Repaglinide—Urticaria—Topiramate—epilepsy syndrome	5.48e-05	0.000411	CcSEcCtD
Repaglinide—Abdominal pain—Topiramate—epilepsy syndrome	5.46e-05	0.000409	CcSEcCtD
Repaglinide—Nausea—Pregabalin—epilepsy syndrome	5.31e-05	0.000398	CcSEcCtD
Repaglinide—Vomiting—Gabapentin—epilepsy syndrome	5.22e-05	0.000391	CcSEcCtD
Repaglinide—Rash—Gabapentin—epilepsy syndrome	5.17e-05	0.000388	CcSEcCtD
Repaglinide—Dermatitis—Gabapentin—epilepsy syndrome	5.17e-05	0.000387	CcSEcCtD
Repaglinide—Headache—Gabapentin—epilepsy syndrome	5.14e-05	0.000385	CcSEcCtD
Repaglinide—Hypersensitivity—Topiramate—epilepsy syndrome	5.08e-05	0.000381	CcSEcCtD
Repaglinide—Pruritus—Topiramate—epilepsy syndrome	4.88e-05	0.000366	CcSEcCtD
Repaglinide—Nausea—Gabapentin—epilepsy syndrome	4.87e-05	0.000365	CcSEcCtD
Repaglinide—Diarrhoea—Topiramate—epilepsy syndrome	4.72e-05	0.000354	CcSEcCtD
Repaglinide—Vomiting—Topiramate—epilepsy syndrome	4.39e-05	0.000329	CcSEcCtD
Repaglinide—Rash—Topiramate—epilepsy syndrome	4.35e-05	0.000326	CcSEcCtD
Repaglinide—Dermatitis—Topiramate—epilepsy syndrome	4.35e-05	0.000326	CcSEcCtD
Repaglinide—Headache—Topiramate—epilepsy syndrome	4.32e-05	0.000324	CcSEcCtD
Repaglinide—Nausea—Topiramate—epilepsy syndrome	4.1e-05	0.000307	CcSEcCtD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.11e-05	0.000131	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.11e-05	0.000131	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—FGF2—epilepsy syndrome	1.1e-05	0.000129	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.09e-05	0.000129	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.08e-05	0.000127	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—UPB1—epilepsy syndrome	1.07e-05	0.000126	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ATIC—epilepsy syndrome	1.07e-05	0.000126	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NEU1—epilepsy syndrome	1.07e-05	0.000126	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—ADRA2A—epilepsy syndrome	1.07e-05	0.000126	CbGpPWpGaD
Repaglinide—ALB—Metabolism—UPB1—epilepsy syndrome	1.06e-05	0.000125	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NEU1—epilepsy syndrome	1.06e-05	0.000125	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ATIC—epilepsy syndrome	1.06e-05	0.000125	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PLAT—epilepsy syndrome	1.06e-05	0.000125	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—HMOX1—epilepsy syndrome	1.05e-05	0.000123	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.04e-05	0.000122	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CAT—epilepsy syndrome	1.03e-05	0.000122	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—HSD17B4—epilepsy syndrome	1.03e-05	0.000121	CbGpPWpGaD
Repaglinide—ALB—Metabolism—HSD17B4—epilepsy syndrome	1.02e-05	0.000121	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—RELA—epilepsy syndrome	1.02e-05	0.00012	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.02e-05	0.00012	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—HMOX1—epilepsy syndrome	1.01e-05	0.00012	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.01e-05	0.000119	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP2D6—epilepsy syndrome	1.01e-05	0.000119	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ABCB1—epilepsy syndrome	1e-05	0.000118	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CAT—epilepsy syndrome	1e-05	0.000118	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NOS1—epilepsy syndrome	9.97e-06	0.000118	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GBE1—epilepsy syndrome	9.94e-06	0.000117	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPP1R3C—epilepsy syndrome	9.94e-06	0.000117	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GBE1—epilepsy syndrome	9.88e-06	0.000116	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPP1R3C—epilepsy syndrome	9.88e-06	0.000116	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ABCB1—epilepsy syndrome	9.74e-06	0.000115	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	9.71e-06	0.000114	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	9.66e-06	0.000114	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ADRA2A—epilepsy syndrome	9.6e-06	0.000113	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—BCHE—epilepsy syndrome	9.56e-06	0.000113	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—SIRT1—epilepsy syndrome	9.38e-06	0.000111	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ASAH1—epilepsy syndrome	9.34e-06	0.00011	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GPX1—epilepsy syndrome	9.34e-06	0.00011	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—AKT3—epilepsy syndrome	9.34e-06	0.00011	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ASAH1—epilepsy syndrome	9.29e-06	0.00011	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—VDR—epilepsy syndrome	9.24e-06	0.000109	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PLAUR—epilepsy syndrome	9.23e-06	0.000109	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	9.18e-06	0.000108	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—SLC2A1—epilepsy syndrome	9.12e-06	0.000107	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—STXBP1—epilepsy syndrome	9.09e-06	0.000107	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ABCG2—epilepsy syndrome	9.08e-06	0.000107	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GPX1—epilepsy syndrome	9.06e-06	0.000107	CbGpPWpGaD
Repaglinide—ALB—Metabolism—STXBP1—epilepsy syndrome	9.04e-06	0.000107	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PLCB1—epilepsy syndrome	9.02e-06	0.000106	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—TH—epilepsy syndrome	8.99e-06	0.000106	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NT5E—epilepsy syndrome	8.86e-06	0.000104	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALAD—epilepsy syndrome	8.86e-06	0.000104	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP2C19—epilepsy syndrome	8.85e-06	0.000104	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.85e-06	0.000104	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NT5E—epilepsy syndrome	8.81e-06	0.000104	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALAD—epilepsy syndrome	8.81e-06	0.000104	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP11A1—epilepsy syndrome	8.8e-06	0.000104	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	8.76e-06	0.000103	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—H2AFX—epilepsy syndrome	8.76e-06	0.000103	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.73e-06	0.000103	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MMP9—epilepsy syndrome	8.69e-06	0.000102	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CDC42—epilepsy syndrome	8.52e-06	0.0001	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—YWHAZ—epilepsy syndrome	8.45e-06	9.96e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CACNA1A—epilepsy syndrome	8.45e-06	9.96e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALDH7A1—epilepsy syndrome	8.45e-06	9.96e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CACNA1A—epilepsy syndrome	8.4e-06	9.9e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALDH7A1—epilepsy syndrome	8.4e-06	9.9e-05	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—NR3C1—epilepsy syndrome	8.32e-06	9.8e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	8.28e-06	9.76e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	8.28e-06	9.76e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ADK—epilepsy syndrome	8.28e-06	9.76e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	8.28e-06	9.76e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	8.28e-06	9.76e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	8.28e-06	9.76e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ST3GAL3—epilepsy syndrome	8.27e-06	9.75e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ST3GAL3—epilepsy syndrome	8.22e-06	9.69e-05	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AGT—epilepsy syndrome	8.19e-06	9.65e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ADSL—epilepsy syndrome	8.1e-06	9.55e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ADSL—epilepsy syndrome	8.05e-06	9.49e-05	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—APOE—epilepsy syndrome	8.02e-06	9.46e-05	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—SRC—epilepsy syndrome	8.01e-06	9.45e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.96e-06	9.39e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GLUL—epilepsy syndrome	7.94e-06	9.36e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AGT—epilepsy syndrome	7.94e-06	9.36e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP2D6—epilepsy syndrome	7.94e-06	9.36e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GLUL—epilepsy syndrome	7.9e-06	9.31e-05	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—VEGFA—epilepsy syndrome	7.8e-06	9.2e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	7.8e-06	9.19e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—APOE—epilepsy syndrome	7.78e-06	9.17e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CACNA1D—epilepsy syndrome	7.75e-06	9.14e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—FYN—epilepsy syndrome	7.59e-06	8.94e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.57e-06	8.93e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	7.57e-06	8.92e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	7.57e-06	8.92e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	7.57e-06	8.92e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	7.57e-06	8.92e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ADRA2A—epilepsy syndrome	7.56e-06	8.91e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—BCHE—epilepsy syndrome	7.53e-06	8.87e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—HMOX1—epilepsy syndrome	7.5e-06	8.84e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CAT—epilepsy syndrome	7.4e-06	8.72e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	7.29e-06	8.6e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—YWHAZ—epilepsy syndrome	7.29e-06	8.6e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TXNRD1—epilepsy syndrome	7.25e-06	8.55e-05	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	7.21e-06	8.49e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ABCB1—epilepsy syndrome	7.2e-06	8.49e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SLC2A1—epilepsy syndrome	7.18e-06	8.46e-05	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	7.14e-06	8.42e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PLCB1—epilepsy syndrome	7.1e-06	8.37e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AQP1—epilepsy syndrome	7.08e-06	8.35e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—TH—epilepsy syndrome	7.08e-06	8.34e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AQP1—epilepsy syndrome	7.04e-06	8.3e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	7.04e-06	8.3e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CA4—epilepsy syndrome	7.04e-06	8.3e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	7.02e-06	8.27e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.97e-06	8.21e-05	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	6.92e-06	8.15e-05	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—POMC—epilepsy syndrome	6.89e-06	8.13e-05	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	6.86e-06	8.09e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.8e-06	8.02e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.76e-06	7.97e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GPX1—epilepsy syndrome	6.69e-06	7.89e-05	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TNF—epilepsy syndrome	6.69e-06	7.88e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—POMC—epilepsy syndrome	6.68e-06	7.88e-05	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	6.68e-06	7.88e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.62e-06	7.8e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PLAU—epilepsy syndrome	6.47e-06	7.63e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	6.4e-06	7.55e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	6.4e-06	7.55e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—KCNJ11—epilepsy syndrome	6.37e-06	7.51e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CHRM3—epilepsy syndrome	6.37e-06	7.51e-05	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ALB—epilepsy syndrome	6.28e-06	7.41e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.27e-06	7.39e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.27e-06	7.39e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.27e-06	7.39e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.27e-06	7.39e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.27e-06	7.39e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ALB—epilepsy syndrome	6.09e-06	7.18e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PRKCB—epilepsy syndrome	6.02e-06	7.09e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.96e-06	7.03e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NOS2—epilepsy syndrome	5.95e-06	7.01e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.93e-06	6.99e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	5.91e-06	6.96e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AGT—epilepsy syndrome	5.87e-06	6.92e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.84e-06	6.89e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CAT—epilepsy syndrome	5.83e-06	6.87e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.81e-06	6.85e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—APOE—epilepsy syndrome	5.75e-06	6.78e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.74e-06	6.76e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.74e-06	6.76e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.74e-06	6.76e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	5.67e-06	6.68e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.52e-06	6.51e-05	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTGS2—epilepsy syndrome	5.5e-06	6.48e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.33e-06	6.29e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.33e-06	6.29e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTGS2—epilepsy syndrome	5.33e-06	6.28e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	5.27e-06	6.21e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	5.22e-06	6.15e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ABCG2—epilepsy syndrome	5.19e-06	6.12e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	5.09e-06	6e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP2C19—epilepsy syndrome	5.06e-06	5.96e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	5.06e-06	5.96e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP11A1—epilepsy syndrome	5.03e-06	5.93e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.02e-06	5.92e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.01e-06	5.91e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.99e-06	5.88e-05	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—AKT1—epilepsy syndrome	4.98e-06	5.87e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—POMC—epilepsy syndrome	4.94e-06	5.82e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.88e-06	5.75e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.75e-06	5.6e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.75e-06	5.6e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AGT—epilepsy syndrome	4.62e-06	5.45e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.58e-06	5.39e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	4.56e-06	5.38e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP2D6—epilepsy syndrome	4.54e-06	5.35e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.54e-06	5.35e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.54e-06	5.35e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APOE—epilepsy syndrome	4.53e-06	5.34e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ALB—epilepsy syndrome	4.5e-06	5.31e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.44e-06	5.23e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.35e-06	5.13e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	4.34e-06	5.12e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—BCHE—epilepsy syndrome	4.33e-06	5.1e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ADRA2A—epilepsy syndrome	4.32e-06	5.09e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—BCHE—epilepsy syndrome	4.3e-06	5.07e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.26e-06	5.03e-05	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	4.26e-06	5.03e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.19e-06	4.93e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	4.13e-06	4.86e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC2A1—epilepsy syndrome	4.1e-06	4.84e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	4.08e-06	4.81e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TH—epilepsy syndrome	4.07e-06	4.79e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PLCB1—epilepsy syndrome	4.06e-06	4.78e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TH—epilepsy syndrome	4.04e-06	4.77e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4e-06	4.72e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.98e-06	4.69e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS2—epilepsy syndrome	3.94e-06	4.64e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.91e-06	4.61e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—POMC—epilepsy syndrome	3.89e-06	4.59e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.8e-06	4.48e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ALB—epilepsy syndrome	3.55e-06	4.18e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SRC—epilepsy syndrome	3.54e-06	4.17e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VEGFA—epilepsy syndrome	3.44e-06	4.06e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.44e-06	4.05e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.44e-06	4.05e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	3.39e-06	4e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—HMOX1—epilepsy syndrome	3.37e-06	3.98e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CAT—epilepsy syndrome	3.35e-06	3.95e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CAT—epilepsy syndrome	3.33e-06	3.93e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	3.26e-06	3.84e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ABCB1—epilepsy syndrome	3.24e-06	3.82e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	3.1e-06	3.66e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GPX1—epilepsy syndrome	3.03e-06	3.57e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GPX1—epilepsy syndrome	3.01e-06	3.55e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.8e-06	3.3e-05	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AKT1—epilepsy syndrome	2.76e-06	3.26e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.73e-06	3.22e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.71e-06	3.2e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AKT1—epilepsy syndrome	2.68e-06	3.16e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AGT—epilepsy syndrome	2.66e-06	3.13e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AGT—epilepsy syndrome	2.64e-06	3.11e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOE—epilepsy syndrome	2.6e-06	3.07e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOE—epilepsy syndrome	2.59e-06	3.05e-05	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—AKT1—epilepsy syndrome	2.55e-06	3e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.45e-06	2.89e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.33e-06	2.75e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.32e-06	2.74e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—POMC—epilepsy syndrome	2.24e-06	2.64e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—POMC—epilepsy syndrome	2.22e-06	2.62e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.21e-06	2.61e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—AKT1—epilepsy syndrome	2.2e-06	2.59e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.19e-06	2.58e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TH—epilepsy syndrome	2.18e-06	2.57e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALB—epilepsy syndrome	2.04e-06	2.4e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AKT1—epilepsy syndrome	1.98e-06	2.33e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.82e-06	2.15e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.8e-06	2.12e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.78e-06	2.1e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS2—epilepsy syndrome	1.77e-06	2.09e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.75e-06	2.06e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.63e-06	1.92e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	1.56e-06	1.84e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.43e-06	1.68e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.4e-06	1.65e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.2e-06	1.41e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.09e-06	1.29e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.57e-07	1.13e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKT1—epilepsy syndrome	8.96e-07	1.06e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKT1—epilepsy syndrome	8.91e-07	1.05e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.81e-07	5.67e-06	CbGpPWpGaD
